Langar Global HealthTech ETF Shifts Listing to Cboe BZX Exchange

Current shareholders face no disruption from this move, as the fund confirms that no action is required from investors. The ETF’s underlying investment objective, management team, and specific strategy remain consistent with the fund’s original prospectus. LGHT continues to focus on long-term capital growth by targeting the intersection of healthcare and technology, specifically digital health, AI-driven diagnostics, and health data infrastructure.

As a subsidiary of Langar Technology, Inc., the firm maintains its position as the manager of this pure-play healthtech vehicle. Investors are reminded that shares are bought and sold at market price rather than net asset value, and that all investments carry the inherent risk of principal loss. Distribution services for the fund continue to be provided by the unaffiliated firm Paralel Distributors LLC.